ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,116.17
      0.32%
      US Tech 100
      17,280.80
      -0.17%
      Dow Jones
      38,386.09
      0.38%
      Brent Oil
      87.515
      0.26%
      Bitcoin
      61,658.01
      -3.41%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ironwood Pharmaceuticals Inc (IRWD)

      7. Ironwood Pharmaceuticals Inc (IRWD) News

      IRWD

      Ironwood Pharmaceuticals (IRWD)

      Ironwood Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IRWD
      DateTimeSourceHeadlineSymbolCompany
      04/25/20244:01PMBusiness WireIronwood Pharmaceuticals to Host First Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
      03/28/20247:30AMBusiness WireIronwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)NASDAQ:IRWDIronwood Pharmaceuticals Inc
      03/08/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      03/07/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      03/06/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/29/20246:00AMBusiness WireIronwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)NASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/23/20247:30AMBusiness WireIronwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/15/20247:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/15/20247:00AMBusiness WireIronwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/14/20249:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/14/20248:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/14/20248:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/14/20248:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/14/20248:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/14/20248:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/09/20244:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/09/20244:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/09/20244:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/09/20244:05PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      02/01/20244:01PMBusiness WireIronwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
      01/19/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      01/19/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      01/19/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      01/19/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
      01/08/20247:00PMBusiness WireIronwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional ConstipationNASDAQ:IRWDIronwood Pharmaceuticals Inc
      01/08/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
      01/08/20246:00AMBusiness WireIronwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
      01/03/20244:01PMBusiness WireIronwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
      12/19/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:IRWD